IORT stands for intraoperative radiation therapy, and it’s exactly what it sounds like, a single, concentrated dose of radiation delivered directly to the tumor bed during a lumpectomy, right after the cancerous tissue comes out. Instead of the usual weeks of daily radiation trips after surgery, the radiation happens once, in the operating room, while the patient is already under anesthesia for the lumpectomy itself.
Dr. Sandeep Nayak, known for the Best Cancer Treatment in Bangalore, explains why the timing matters so much here. “The tumor bed is wide open right after the tumor comes out, which is actually the ideal moment to target it directly. We’re aiming the radiation exactly where residual cancer cells are most likely to be, with far less healthy tissue in the path compared to radiating the whole breast from outside over several weeks.”
Curious whether IORT applies to your own diagnosis?
How IORT Actually Works?
The procedure adds a focused step to the lumpectomy itself, without requiring a separate surgery or a separate day:
- Once the surgeon removes the tumor, a radiation applicator is placed directly into the tumor bed while the patient remains under anesthesia
- The radiation dose is delivered over roughly twenty to thirty minutes, aimed precisely at the tissue immediately surrounding where the tumor sat
- The applicator is removed and the surgery concludes normally, with no additional radiation sessions needed for eligible patients
- Final pathology results are reviewed afterward, and in some cases, additional external radiation may still be recommended depending on what they show
This entire radiation component happens within the same surgical window, which is the core difference from how radiation is typically delivered after breast-conserving surgery.
Who Is Actually a Good Candidate for This?
IORT isn’t offered to every breast cancer patient, eligibility depends on specific tumor characteristics:
- Small, early-stage tumors with node-negative disease tend to be the best fit for this approach
- Clear surgical margins on the lumpectomy specimen matter significantly in determining whether IORT alone is sufficient
- Patients with larger tumors, positive lymph nodes, or certain aggressive tumor characteristics are usually better suited to conventional radiation delivered over several weeks instead
- The decision is made based on actual pathology and imaging, not general preference for a shorter treatment course
For patients weighing breast-conserving surgery against mastectomy in the first place, that decision usually comes before the IORT eligibility conversation even starts.
Why Choose MACS Clinic for IORT and Breast Cancer Surgery?
Dr. Sandeep Nayak’s team evaluates tumor characteristics and pathology carefully before recommending IORT, rather than presenting it as an option to every patient regardless of fit. For eligible patients, this approach can mean completing radiation the same day as surgery, changing what recovery looks like practically compared to weeks of follow-up appointments.
Want to know if IORT fits your specific diagnosis? Reach the team at +91 9482202240.
FAQs
Does IORT replace all other radiation entirely?
For eligible patients, often yes. Some patients still need additional external radiation afterward if final pathology shows something unexpected.
Is IORT as effective as conventional whole-breast radiation?
For appropriately selected early-stage patients, studies have shown comparable outcomes. It isn’t a fit for every case, which is why eligibility gets assessed carefully.
Does IORT extend the time spent in surgery?
It adds roughly twenty to thirty minutes to the procedure, since the radiation happens while the patient is already under anesthesia for the lumpectomy.
Will I know before surgery if I'm a candidate for IORT?
In most cases, yes, based on pre-surgical imaging and biopsy results, though final eligibility is sometimes confirmed once the tumor is removed and examined.
References
- Correa C, et al. (2017). Accelerated partial breast irradiation:
PubMed – ASTRO consensus statement (pubmed.ncbi.nlm.nih.gov) - Hepel JT, et al. (2017). Accelerated partial breast irradiation: Executive summary for the update of an ASTRO evidence-based
PubMed – ASTRO guidance (pubmed.ncbi.nlm.nih.gov)
Disclaimer:This content is published for educational and informational purposes only.